Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004979437 | SCV005571598 | uncertain significance | Inborn genetic diseases | 2024-07-10 | criteria provided, single submitter | clinical testing | The c.5572T>G (p.Y1858D) alteration is located in exon 50 (coding exon 50) of the DYSF gene. This alteration results from a T to G substitution at nucleotide position 5572, causing the tyrosine (Y) at amino acid position 1858 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |